CH, C., HH, H., TH, W., TW, K., NC, H., KY, H., . . . KW, L. (2026). A prognostic 19-gene signature and LBP-mediated immune dysregulation define the tumor microenvironment in poor-prognosis KIRC. International journal of medical sciences, 23(3), 824. https://doi.org/10.7150/ijms.125505
Chicago Style (17th ed.) CitationCH, Chen, et al. "A Prognostic 19-gene Signature and LBP-mediated Immune Dysregulation Define the Tumor Microenvironment in Poor-prognosis KIRC." International Journal of Medical Sciences 23, no. 3 (2026): 824. https://doi.org/10.7150/ijms.125505.
MLA (9th ed.) CitationCH, Chen, et al. "A Prognostic 19-gene Signature and LBP-mediated Immune Dysregulation Define the Tumor Microenvironment in Poor-prognosis KIRC." International Journal of Medical Sciences, vol. 23, no. 3, 2026, p. 824, https://doi.org/10.7150/ijms.125505.